pteridines has been researched along with Benign Neoplasms, Brain in 11 studies
Excerpt | Relevance | Reference |
---|---|---|
"Glioblastoma (GBM) is the deadliest primary brain tumor that is highly resistant to current treatments." | 1.56 | Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC. ( Chen, G; Deng, Z; Feng, M; Feng, Z; Li, X; Li, Y; Pan, T; Tao, Z; Wang, H; Yin, H; Zhao, G; Zhou, Y, 2020) |
"Medulloblastoma is the most common malignant brain tumor in children." | 1.39 | Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children. ( Berns, R; Bouffet, E; Dunham, C; Dunn, SE; Foster, C; Fotovati, A; Hawkins, C; Hukin, J; Lee, C; Manoranjan, B; Narendran, A; Northcott, P; O'Halloran, K; Pambid, MR; Ramaswamy, V; Rassekh, R; Singh, SK; Singhal, A; Taylor, MD; Triscott, J; Venugopal, C; Yip, S, 2013) |
"Gliomas are the most devastating of primary adult malignant brain tumors." | 1.38 | Glioma-propagating cells as an in vitro screening platform: PLK1 as a case study. ( Ang, BT; Brooks, HB; Campbell, RM; Chong, YK; Foong, CS; Sandanaraj, E; Tang, C, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (72.73) | 24.3611 |
2020's | 3 (27.27) | 2.80 |
Authors | Studies |
---|---|
Li, X | 2 |
Tao, Z | 2 |
Wang, H | 2 |
Deng, Z | 2 |
Zhou, Y | 2 |
Du, Z | 1 |
Feng, M | 1 |
Zhao, G | 1 |
Yin, H | 1 |
Pan, T | 1 |
Chen, G | 1 |
Feng, Z | 1 |
Li, Y | 1 |
Zhu, Z | 1 |
Wang, J | 1 |
Tan, J | 1 |
Yao, YL | 1 |
He, ZC | 1 |
Xie, XQ | 1 |
Yan, ZX | 1 |
Fu, WJ | 1 |
Liu, Q | 1 |
Wang, YX | 1 |
Luo, T | 1 |
Bian, XW | 1 |
Schmidt, C | 1 |
Schubert, NA | 1 |
Brabetz, S | 1 |
Mack, N | 1 |
Schwalm, B | 1 |
Chan, JA | 1 |
Selt, F | 1 |
Herold-Mende, C | 1 |
Witt, O | 1 |
Milde, T | 1 |
Pfister, SM | 1 |
Korshunov, A | 1 |
Kool, M | 1 |
Triscott, J | 2 |
Lee, C | 2 |
Foster, C | 1 |
Manoranjan, B | 1 |
Pambid, MR | 1 |
Berns, R | 1 |
Fotovati, A | 2 |
Venugopal, C | 2 |
O'Halloran, K | 1 |
Narendran, A | 2 |
Hawkins, C | 1 |
Ramaswamy, V | 1 |
Bouffet, E | 1 |
Taylor, MD | 1 |
Singhal, A | 2 |
Hukin, J | 1 |
Rassekh, R | 1 |
Yip, S | 2 |
Northcott, P | 1 |
Singh, SK | 2 |
Dunham, C | 2 |
Dunn, SE | 2 |
Danovi, D | 1 |
Folarin, A | 1 |
Gogolok, S | 1 |
Ender, C | 1 |
Elbatsh, AM | 1 |
Engström, PG | 1 |
Stricker, SH | 1 |
Gagrica, S | 1 |
Georgian, A | 1 |
Yu, D | 1 |
U, KP | 1 |
Harvey, KJ | 1 |
Ferretti, P | 1 |
Paddison, PJ | 1 |
Preston, JE | 1 |
Abbott, NJ | 1 |
Bertone, P | 1 |
Smith, A | 1 |
Pollard, SM | 1 |
Amani, V | 1 |
Prince, EW | 1 |
Alimova, I | 1 |
Balakrishnan, I | 1 |
Birks, D | 1 |
Donson, AM | 1 |
Harris, P | 1 |
Levy, JM | 1 |
Handler, M | 1 |
Foreman, NK | 1 |
Venkataraman, S | 1 |
Vibhakar, R | 1 |
Xiao, D | 1 |
Yue, M | 1 |
Su, H | 1 |
Ren, P | 1 |
Jiang, J | 1 |
Li, F | 1 |
Hu, Y | 1 |
Du, H | 1 |
Liu, H | 1 |
Qing, G | 1 |
Grinshtein, N | 1 |
Datti, A | 1 |
Fujitani, M | 1 |
Uehling, D | 1 |
Prakesch, M | 1 |
Isaac, M | 1 |
Irwin, MS | 1 |
Wrana, JL | 1 |
Al-Awar, R | 1 |
Kaplan, DR | 1 |
Chen, J | 1 |
Kerr, JM | 1 |
Verreault, M | 1 |
Wakimoto, H | 1 |
Jones, C | 1 |
Jayanthan, A | 1 |
Foong, CS | 1 |
Sandanaraj, E | 1 |
Brooks, HB | 1 |
Campbell, RM | 1 |
Ang, BT | 1 |
Chong, YK | 1 |
Tang, C | 1 |
11 other studies available for pteridines and Benign Neoplasms, Brain
Article | Year |
---|---|
Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodioxoles; Brain Neoplasms; Cell Cycle Proteins; Cell | 2020 |
Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Carcinogenesis; Cell Cycle Proteins; Cel | 2020 |
Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target.
Topics: Adult; Aged; Animals; Apoptosis; Brain Neoplasms; Calcium-Binding Proteins; Cell Cycle; Cell Prolife | 2021 |
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Proliferation; Ch | 2017 |
Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.
Topics: Adolescent; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Cycle Proteins; Child; Child, Pres | 2013 |
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1.
Topics: Animals; Benzimidazoles; Blood-Brain Barrier; Blotting, Western; Brain Neoplasms; Cell Cycle Checkpo | 2013 |
Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
Topics: Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damag | 2016 |
Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle | 2016 |
Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.
Topics: Algorithms; Animals; Brain Neoplasms; Cell Cycle Proteins; Cells, Cultured; High-Throughput Screenin | 2011 |
Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; D | 2012 |
Glioma-propagating cells as an in vitro screening platform: PLK1 as a case study.
Topics: Animals; Brain Neoplasms; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Computational Biol | 2012 |